|
|
|
|
|
|
|
|
|
|
Data From Studies of Pfizer Neurontin Drug May Have Been Skewed - Bloomberg.com
Nov. 11 (Bloomberg) -- Researchers say trials of Pfizer Inc.’s Neurontin epilepsy treatment for uses that were not yet approved may have been skewed to emphasize favorable results.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.